Skip to main content
NIOX GROUP PLC logo

NIOX GROUP PLC — Investor Relations & Filings

Ticker · NIOX ISIN · GB00BJVD3B28 LEI · 2138006YAT138TOGA556 IL Manufacturing
Filings indexed 147 across all filing types
Latest filing 2024-03-28 Remuneration Information
Country GB United Kingdom
Listing IL NIOX

About NIOX GROUP PLC

https://www.niox.com/

NIOX Group PLC is a medical device company specializing in the design, development, and commercialization of products for asthma diagnosis and management. The company's core offering is the NIOX® product line, which provides point-of-care measurement of Fractional exhaled Nitric Oxide (FeNO). This non-invasive diagnostic tool is used by physicians globally to help improve the diagnosis and management of asthma, with the aim of enhancing the quality of life for individuals with the condition.

Recent filings

Filing Released Lang Actions
Director/PDMR Shareholding
Remuneration Information Classification · 1% confidence The document is an official notification filed via RNS (RNS Number : 7922I) on March 28, 2024. The content explicitly details share awards granted to Executive Directors under a Deferred Share Bonus Plan and subsequent sales to satisfy tax liabilities. It includes detailed tables of transactions, resulting interests, and voting rights, structured according to regulatory disclosure requirements (specifically mentioning UK MAR and FCA Disclosure and Transparency Rules). This type of filing, reporting personal share transactions by company directors and executives (insider trades), directly matches the definition for Director's Dealing (DIRS). It is not a general regulatory filing (RNS) because it fits a more specific category, nor is it a remuneration report (DEF 14A) as it focuses on the transaction itself rather than the overall compensation policy.
2024-03-28 English
Grant of options
Remuneration Information Classification · 1% confidence The document is an official announcement disseminated via RNS (RNS Number: 7715I) from Niox Group PLC on March 28, 2024. The primary content details the 'Grant of options' to Executive Directors under a Performance Share Plan. Crucially, the announcement includes a section titled 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them' (PDMR dealing). This specific disclosure relates to insider transactions (granting of options to directors). While the grant of options is a form of capital/share activity, the mandatory disclosure format strongly aligns with reporting insider dealings. The definition for Director's Dealing (DIRS) is 'Report of personal share transactions by company directors and executives (insider trades)'. Since this document explicitly reports transactions by PDMRs (Executive Directors), DIRS is the most precise classification. The document is short and is a direct announcement, not a summary of a larger report, thus ruling out RPA/RNS as the primary type, although it uses the RNS distribution system.
2024-03-28 English
Exercise of SAYE Options
Director's Dealing Classification · 1% confidence The document is an official announcement released via RNS (London Stock Exchange news service) on March 27, 2024. The content details the exercise of SAYE options by directors and subsequently discloses the resulting change in their shareholdings and the total voting rights of the company. The final section explicitly provides 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them' (PDMR dealing). This combination of director/insider transaction disclosure and voting rights update strongly aligns with the definition of Director's Dealing (DIRS). While it is a regulatory filing (RNS), DIRS is the more specific category for insider transactions.
2024-03-27 English
Final Results
Earnings Release Classification · 1% confidence The document is an 'Earnings Release' (ER) for Niox Group PLC for the year ended 31 December 2023. It contains key financial highlights, operational highlights, management commentary, and forward-looking statements. While it mentions that the full annual report will be available on the website, the document itself provides substantive financial data and analysis, distinguishing it from a mere 'Report Publication Announcement' (RPA). FY 2023
2024-03-26 English
Block Admission
Share Issue/Capital Change Classification · 1% confidence The document is a short announcement (2220 chars) identified by the 'RNS Number' header and explicitly states that an application has been made for a 'block admission' of new ordinary shares to be issued under a Deferred Share Bonus Plan. This action directly relates to changes in the company's share capital structure and issuance of new shares. This fits the definition of 'Share Issue/Capital Change' (SHA). Although it is an RNS announcement, the specific nature of the announcement (block admission for bonus plan shares) is more precise than the general fallback (RNS). It is not a financing update (CAP) as it relates to employee compensation/share issuance, not general fundraising.
2024-03-22 English
Total Voting Rights Update
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official notification identified by the 'RNS Number' and the reference to the 'London Stock Exchange' and 'FCA's Disclosure and Transparency Rule 5.6.1'. The content explicitly states a 'Total Voting Rights Update' following the exercise of share options, confirming the total number of shares in issue (422,120,630). This type of announcement, which updates the denominator for shareholder notification purposes, is a standard regulatory disclosure. While it relates to share capital changes, it is primarily a mandatory disclosure of voting rights status, which fits best under the general 'Regulatory Filings' (RNS) category, as there is no specific code for 'Total Voting Rights Update' and it is not a comprehensive capital change announcement (SHA) or a director's dealing (DIRS). Given the source (RNS) and the nature of the mandatory disclosure, RNS is the most appropriate classification.
2024-03-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.